Onward Medical N.V. (ONWD.BR)
EUR 3.82
(-0.65%)
EUR 3.82
(-0.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.20 EUR | -10.09% |
| 2022 | -1.09 EUR | 4.39% |
| 2021 | -1.14 EUR | -18.75% |
| 2020 | -0.96 EUR | -47.69% |
| 2019 | -0.65 EUR | -35.42% |
| 2018 | -0.48 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.27 EUR | 3.57% |
| 2024 Q2 | -0.27 EUR | 3.7% |
| 2023 Q1 | -0.32 EUR | 42.86% |
| 2023 FY | - EUR | -10.09% |
| 2023 Q4 | -0.28 EUR | 0.0% |
| 2023 Q3 | -0.28 EUR | 56.25% |
| 2023 Q2 | -0.64 EUR | -100.0% |
| 2022 Q1 | -0.27 EUR | 63.01% |
| 2022 Q3 | -0.28 EUR | 47.17% |
| 2022 Q4 | -0.56 EUR | -100.0% |
| 2022 Q2 | -0.53 EUR | -96.3% |
| 2022 FY | - EUR | 4.39% |
| 2021 Q1 | -1.62 EUR | -9.46% |
| 2021 FY | - EUR | -18.75% |
| 2021 Q4 | -0.73 EUR | 0.0% |
| 2021 Q3 | -0.73 EUR | 54.94% |
| 2021 Q2 | -1.62 EUR | 0.0% |
| 2020 Q2 | -1.29 EUR | 0.0% |
| 2020 Q3 | -1.48 EUR | -14.73% |
| 2020 Q1 | -1.29 EUR | 0.0% |
| 2020 FY | - EUR | -47.69% |
| 2020 Q4 | -1.48 EUR | 0.0% |
| 2019 FY | - EUR | -35.42% |
| 2018 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Nicox S.A. | -0.42 EUR | -185.714% |
| European Medical Solutions | -0.00 EUR | -239900.0% |
| FERMENTALG | -0.32 EUR | -275.0% |
| argenx SE | -4.67 EUR | 74.304% |
| BioSenic S.A. | -0.21 EUR | -471.429% |
| Celyad Oncology SA | -0.33 EUR | -263.636% |
| Hyloris Pharmaceuticals SA | -0.55 EUR | -118.182% |
| Oxurion NV | -0.01 EUR | -10334.783% |
| PHAXIAM Therapeutics S.A. | -5.00 EUR | 76.0% |
| Financière de Tubize SA | 1.98 EUR | 160.606% |
| UCB SA | 1.81 EUR | 166.298% |